Ozone Infusion Therapy: How MAH Works, Evidence, Safety, and Costs

Ozone infusion therapy is the most common systemic ozone treatment offered in integrative medicine clinics across the United States. Usually called major autohemotherapy (MAH), the procedure involves drawing a small volume of your blood, mixing it with medical-grade ozone gas, and reinfusing the treated blood through the same IV line. It is distinct from standard IV vitamin infusions, and the two should not be confused. This article covers what ozone infusion therapy actually involves, how it differs from other ozone delivery methods, what the evidence says, and what you should know before booking a session.

What Ozone Infusion Therapy Actually Is

The term “ozone infusion therapy” gets used loosely in clinic marketing, but it almost always refers to major autohemotherapy (MAH). Here is the precise procedure:

1. Blood draw. 100 to 300 mL of venous blood is drawn into a sterile glass bottle or specialized bag. This is roughly the same volume as a standard blood donation sample.
2. Ozone mixing. A medical ozone generator produces a precise concentration of ozone gas (typically 20 to 70 mcg/mL) mixed with pure oxygen. This gas is introduced into the collection vessel and gently mixed with the blood.
3. Reaction. When ozone contacts blood, it reacts immediately with plasma components, lipids, and cell membranes. The ozone itself is consumed within seconds. What remains are reactive oxygen species (ROS) and lipid oxidation products (LOPs) that act as signaling molecules.
4. Reinfusion. The ozonated blood is returned to the patient through the same IV line. The process takes 30 to 60 minutes for the infusion itself, with total session time of 45 to 90 minutes including setup.

The critical point: the ozone never enters your body directly. It reacts with the blood outside the body, and the biological products of that reaction are what gets infused. This is fundamentally different from direct IV ozone injection, which carries significantly higher risks.

MAH vs. Direct IV Ozone: An Important Distinction

Some clinics offer direct intravenous ozone, where ozone gas is injected directly into a vein. This is a different procedure with a different risk profile:

A 2025 case report documented severe neurological complications, including ischemic infarcts and persistent cognitive deficits, following direct intravenous ozone therapy.¹ MAH does not carry this specific risk because gas is never introduced directly into the venous system.

If you are evaluating ozone infusion therapy, confirm that the clinic uses MAH (autohemotherapy), not direct IV injection.

How It Differs from Standard IV Infusions

Many integrative clinics offer both ozone infusion and standard IV nutrient infusions (Myers’ cocktail, high-dose vitamin C, glutathione, NAD+, etc.). Patients sometimes confuse the two. They are fundamentally different:

• Standard IV infusion: Delivers nutrients, vitamins, or medications directly into the bloodstream. Nothing is taken out. The IV bag goes in one direction.
• Ozone infusion (MAH): Blood comes out, gets treated, and goes back in. It is a closed-loop system using your own blood as the delivery vehicle.

Some clinics combine both in a single session, running an ozone infusion first and then following with an IV nutrient drip. Others offer “10-pass” ozone therapy, a high-dose version of MAH where the draw-ozonate-reinfuse cycle is repeated 10 times in one session using a specialized device (Herrmann Hyper-Medozon).

Proposed Mechanisms of Action

When ozone contacts blood, it triggers a cascade of biochemical reactions:

• Nrf2 pathway activation. The controlled oxidative stress from ozone activates the Nrf2/Keap1/ARE pathway, which upregulates the body’s own antioxidant enzymes: superoxide dismutase, catalase, glutathione peroxidase, and heme oxygenase-1.²
• Improved oxygen delivery. Ozone increases 2,3-DPG in red blood cells, which causes hemoglobin to release oxygen more readily to tissues. This is sometimes called the “Bohr effect enhancement.”
• Immune modulation. Ozone exposure affects cytokine production, with low doses tending toward anti-inflammatory effects and higher doses having more pro-inflammatory immune-stimulating effects.
• Improved red blood cell flexibility. Ozonated red blood cells become more deformable, which improves their ability to navigate through small capillaries and deliver oxygen to tissues.
• Mitochondrial effects. Some research suggests that ozone therapy may improve mitochondrial function and cellular energy production, though this is less well characterized than the antioxidant pathway effects.

“Ozonated blood allows for the use of ozone in a safe modality, as plasma and blood cells are endowed with an antioxidant system able to quench ozone’s pro-oxidant property.”
ACS Omega, 2023

What the Evidence Shows

MAH has the largest body of research among ozone delivery methods. More than 500 studies have been published, spanning several decades. However, the quality of this evidence is uneven:

Where the Evidence Is Strongest

• Postherpetic neuralgia. A randomized controlled trial found that ozone autohemotherapy combined with pharmacological therapy significantly improved pain outcomes compared to pharmacological therapy alone.³
• Chronic wound healing. Multiple studies support ozone therapy as an adjunct for diabetic foot ulcers and chronic wounds.
• Musculoskeletal pain. Ozone injections (though typically local, not MAH) have evidence for herniated disc and joint pain.

Where Evidence Is Emerging

• Immune modulation. The Italian Scientific Society of Oxygen-Ozone Therapy has published protocol guidelines based on clinical experience and smaller studies showing cytokine modulation and immune cell activation.²
• Chronic infections. Clinical reports suggest benefit for chronic Lyme disease, Epstein-Barr virus, and hepatitis, but large controlled trials are lacking.
• Cardiovascular support. Some studies show improved peripheral circulation and endothelial function after MAH courses.

Where Evidence Is Insufficient

• Cancer. Despite claims from some clinics, there is no quality evidence that MAH treats cancer. It may have a role in managing treatment side effects, but this needs proper trials.
• Anti-aging. Marketing claims about ozone therapy reversing aging are not supported by clinical evidence.
• Neurological conditions. Early-stage research only. Not enough to make clinical recommendations.

Safety Profile

The safety data for MAH is reassuring when the procedure is performed correctly:

• The World Federation of Ozone Therapy evaluated over 300,000 ozone therapy treatments and reported an adverse event rate of 6 per 100,000 treatments. All adverse events were classified as minor.⁴
• Common minor side effects include fatigue, mild headache, and Herxheimer reactions (temporary symptom flare from pathogen die-off) in patients being treated for infections.
• Serious complications from MAH specifically are extremely rare in the published literature.

That said, ozone therapy is not without regulatory concern. The FDA has stated that ozone is a toxic gas with no known useful medical application in specific, adjunctive, or preventive therapy. Cleveland Clinic notes that ozone therapy lacks robust evidence of efficacy from large-scale clinical trials.⁵

Comparison with Other Ozone Routes

MAH is one of several ways to receive ozone therapy. Here is how the main methods compare:

For more on MAH specifically, see our guide to ozone blood therapy.

What a Session Looks Like

Here is a step-by-step walkthrough of a typical MAH session:

1. Arrival and preparation. You sit in a comfortable reclining chair. The practitioner reviews your health status and any changes since your last visit.
2. IV placement. A standard IV catheter is placed in your arm, similar to any blood draw or IV infusion.
3. Blood collection. 100 to 300 mL of blood flows by gravity into a sterile glass bottle. This takes a few minutes.
4. Ozone introduction. The practitioner uses a medical ozone generator to produce a precise concentration of ozone-oxygen gas. This gas is introduced into the blood bottle and gently swirled to mix.
5. Reinfusion. The ozonated blood (which has turned a brighter red color due to increased oxygenation) flows back into your vein by gravity. This takes 15 to 30 minutes.
6. Post-treatment. The IV is removed. Many patients feel energized afterward. Some feel temporarily fatigued. You can drive yourself home and resume normal activities.

Cost and Frequency

Standard MAH sessions cost $200 to $400. High-dose 10-pass sessions run $800 to $1,500. Insurance does not cover ozone therapy.

Typical treatment protocols:

• Acute conditions: 2 to 3 sessions per week for 2 to 4 weeks
• Chronic conditions: 1 session per week for 10 to 20 sessions, then monthly maintenance
• General wellness: Monthly or bi-monthly sessions

An initial course of 10 sessions at average pricing runs $2,000 to $4,000.

The Bottom Line

Ozone infusion therapy (MAH) is the most studied and safest form of systemic ozone treatment available. It has a strong safety record, plausible biological mechanisms, and a growing body of clinical research. But it remains outside mainstream medicine, lacks FDA approval, and does not yet have the large randomized controlled trials that would establish it as a proven treatment for specific conditions.

If you are considering ozone infusion therapy, choose a clinic that uses MAH (not direct IV ozone), employs proper medical-grade equipment, and can have an honest conversation about what the evidence does and does not support for your specific situation.

1. Rahmani F, Ghorani-Azam A, Soltani F. Neurological Crisis Following Intravenous Ozone Therapy: A Case Report. Arch Anesthesiol Crit Care. 2025;11(1):56-59. doi:10.18502/aacc.v11i1.17747
2. Chirumbolo S, Valdenassi L, Simonetti V, et al. The Oxygen-Ozone Adjunct Medical Treatment According to the Protocols from the Italian Scientific Society of Oxygen-Ozone Therapy. Int J Mol Sci. 2023;24(24):17509. doi:10.3390/ijms242417509
3. Zeng J, Lei L, Zeng Q, et al. The effect and safety of ozone autohemotherapy combined with pharmacological therapy in postherpetic neuralgia. J Pain Res. 2018;11:1637-1643. doi:10.2147/JPR.S154154
4. International Scientific Committee of Ozone Therapy (ISCO3). Major Autohemotherapy Protocol. Madrid Declaration on Ozone Therapy. 2nd ed. 2012.
5. Cleveland Clinic. Ozone Therapy: What It Is, Uses and Side Effects. Cleveland Clinic Health Essentials. 2024.

Seph Fontane Pennock

Author

Seph Fontane Pennock is the founder of BaricBoost.com and Regenerated.com, a clinic directory for regenerative medicine serving 10,000+ providers across the United States. He previously built and sold PositivePsychology.com, which grew to 19 million users and became the largest evidence-based positive psychology resource on the web. Seph brings direct experience as an HBOT patient, having completed protocols at clinics across three continents while navigating mold illness, systemic inflammation, and autoimmune conditions. His treatment journey includes hyperbaric oxygen therapy, peptide protocols, NAD+ therapy, and consultations with specialists from Dubai to Cape Town to Mexico. This combination of entrepreneurial track record and lived patient experience shapes everything published on BaricBoost.com. Every article is grounded in peer-reviewed research, informed by real clinical encounters, and written for patients making high-stakes treatment decisions. Seph's focus is on bringing transparency, scientific rigor, and practical guidance to the hyperbaric oxygen therapy space.

Website